Tag: Lung Diseases

Praedicare Leverages AI, Mathematical Models of Disease Progression and Mapping in World’s First In Silico Clinical Trial of Its Kind

sarah JonasResearch Results

The in silico trial demonstrated 2X the efficacy of the current treatment (>80% vs 39%); 3X shorter treatment time to cure (6 vs 18 months); 1 drug compared to a 3-drug combo for the standard of care; and preclinical results in shorter time than animal models.

Lung Disease Physicians and Researchers Disappointed by Environmental Protection Agency’s Slow-Motion Action to Curb Smog Ozone Air Pollution

sarah JonasPolicy

In response to the Aug 21 announcement by the U.S. Environmental Protection Agency (EPA) that the agency will delay action on lowering the National Ambient Air Quality Standard for ozone pollution, American Thoracic Society President M. Patricia Rivera, MD, ATSF, issued the following statement

Pitt researchers led the largest-ever series of phage therapy case studies

sarah JonasResearch Results

In a new paper published today in the journal Clinical Infectious Diseases, a team led by researchers from the University of Pittsburgh and the University of California San Diego report 20 new case studies on the use of the experimental treatment, showing the therapy’s success in more than half of the patients.

Resolve to talk to your doctor in the New Year

sarah JonasFeature

Due to COVID-19, it’s important to talk to your doctor right away if you’re experiencing symptoms such as shortness of breath or cough. Take notes about your symptoms, so your doctor can pinpoint if they are early warning signs of another respiratory disease such as pulmonary fibrosis (PF).